Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.
Koleini N, Santiago JJ, Nickel BE, Sequiera GL, Wang J, Fandrich RR, Jassal DS, Dhingra S, Kirshenbaum LA, Cattini PA, Kardami E.
Koleini N, et al. Among authors: sequiera gl.
Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H279-H288. doi: 10.1152/ajpheart.00587.2018. Epub 2018 Nov 9.
Am J Physiol Heart Circ Physiol. 2019.
PMID: 30412444
Free article.